Recurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation using electronic health record data

<h2>Summary</h2><h3>Background</h3> Predicting outcomes of patients with COVID-19 at an early stage is crucial for optimised clinical care and resource management, especially during a pandemic. Although multiple machine learning models have been proposed to address this issue, because of their requirements for extensive data preprocessing and feature engineering, they have not been validated or implemented outside of their original study site. Therefore, we aimed to develop accurate and transferrable predictive models of outcomes on hospital admission for patients with COVID-19. <h3>Methods</h3> In this study, we developed recurrent neural network-based models (CovRNN) to predict the outcomes of patients with COVID-19 by use of available electronic health record data on admission to hospital, without the need for specific feature selection or missing data imputation. CovRNN was designed to predict three outcomes: in-hospital mortality, need for mechanical ventilation, and prolonged hospital stay (>7 days). For in-hospital mortality and mechanical ventilation, CovRNN produced time-to-event risk scores (survival prediction; evaluated by the concordance index) and all-time risk scores (binary prediction; area under the receiver operating characteristic curve [AUROC] was the main metric); we only trained a binary classification model for prolonged hospital stay. For binary classification tasks, we compared CovRNN against traditional machine learning algorithms: logistic regression and light gradient boost machine. Our models were trained and validated on the heterogeneous, deidentified data of 247 960 patients with COVID-19 from 87 US health-care systems derived from the Cerner Real-World COVID-19 Q3 Dataset up to September 2020. We held out the data of 4175 patients from two hospitals for external validation. The remaining 243 785 patients from the 85 health systems were grouped into training (n=170 626), validation (n=24 378), and multi-hospital test (n=48 781) sets. Model performance was evaluated in the multi-hospital test set. The transferability of CovRNN was externally validated by use of deidentified data from 36 140 patients derived from the US-based Optum deidentified COVID-19 electronic health record dataset (version 1015; from January, 2007, to Oct 15, 2020). Exact dates of data extraction were masked by the databases to ensure patient data safety. <h3>Findings</h3> CovRNN binary models achieved AUROCs of 93·0% (95% CI 92·6–93·4) for the prediction of in-hospital mortality, 92·9% (92·6–93·2) for the prediction of mechanical ventilation, and 86·5% (86·2–86·9) for the prediction of a prolonged hospital stay, outperforming light gradient boost machine and logistic regression algorithms. External validation confirmed AUROCs in similar ranges (91·3–97·0% for in-hospital mortality prediction, 91·5–96·0% for the prediction of mechanical ventilation, and 81·0–88·3% for the prediction of prolonged hospital stay). For survival prediction, CovRNN achieved a concordance index of 86·0% (95% CI 85·1–86·9) for in-hospital mortality and 92·6% (92·2–93·0) for mechanical ventilation. <h3>Interpretation</h3> Trained on a large, heterogeneous, real-world dataset, our CovRNN models showed high prediction accuracy and transferability through consistently good performances on multiple external datasets. Our results show the feasibility of a COVID-19 predictive model that delivers high accuracy without the need for complex feature engineering. <h3>Funding</h3> Cancer Prevention and Research Institute of Texas.